glp 1 drugs tirzepatide Study flags need to monitor frailty risks with GLP-1 for older adults Tirzepatide | DirectMeds

13,14,15 By integrating the latest clinical trial data, we explore the efficacy of GLP-1RAs in treating diseases of the nervous, cardiovascular, endocrine, and digestive systems

Short peptides act through recurring motifs, direct binding and modulation of protein complexes, allosteric activation of signaling enzymes, organelle tethering, and extracellular endocrine signaling, which converge on core hallmarks of aging and explain how peptide loss accelerates tissue decline while restoration or exogenous administration often improves function and extends healthspan in model systems

Richter, S

Its FDA-approved to improve blood sugar in adults with type 2 diabetes